Suppression of experimetal autoimmune encephalomyelitis by cannabinoids

Itzhak Wirguin, Raphael Mechoulam, Aviva Breuer, Elli Schezen, Joseph Weidenfeld, Talma Brenner

Research output: Contribution to journalArticlepeer-review

114 Scopus citations

Abstract

The effect of Δ8-THC on experimental autoimmune encephalomyelitis (EAE) was examined. Δ8-THC is an analogue of Δ9-THC, the psychoactive component of marihuana. It is more stable and less psychotropic than Δ9-THC and like the latter it binds to the brain cannabinoid receptor. Two strains of rats were incolulated for EAE, and Δ8-THC (40 mg/kg) was administered for up to 21 days. Δ8-THC significantly reduced the incidence and severity of neurological deficit in both rat strains. The beneficial influence of Δ8-THC only occured on oral administration and not with parenteral injection. Serum corticosterone levels were twofold elevated in rats with EAE chronically treate with Δ8-THC. These results suggest that suppression of EAE cannabinoids may be related to their effect on corticosterone secretion.

Original languageEnglish
Pages (from-to)209-214
Number of pages6
JournalImmunopharmacology
Volume28
Issue number3
DOIs
StatePublished - 1 Jan 1994
Externally publishedYes

Keywords

  • Cannabinoids
  • Corticosterone
  • Experimental autoimmune ecephalomyelitis
  • HU-211
  • Δ-Tetrahydrocannabinol

ASJC Scopus subject areas

  • Pharmacology

Fingerprint

Dive into the research topics of 'Suppression of experimetal autoimmune encephalomyelitis by cannabinoids'. Together they form a unique fingerprint.

Cite this